Key result
Thrombosis during head and neck cancer treatment occurred in various arterial and venous sites, leading to sudden death in 2 out of 4 reported cases.
Why the study?
Cancer patients are predisposed to thrombosis due to hypercoagulability and endothelial injury from treatments, but diverse thrombotic complications occur during head and neck cancer management.
Thrombosis is a potentially fatal complication during head and neck cancer treatment, particularly with cisplatin-based regimens, anti-EGFR agents, and central venous catheters.
Answers are grounded in this paper and cite their sources.
Thrombosis warrants vigilance during head and neck cancer therapy; leaves open the need for prospective incidence and prevention studies.
No abstract yet. The journal hasn't published one we can show.
No takes yet. Share an insight, caveat, or question.
Matsuo et al. (2020) studied this question. Thrombosis during head and neck cancer treatment occurred in various arterial and venous sites, leading to sudden death in 2 out of 4 reported cases.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: